Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cone-rod dystrophy in which the cause of the disease is a mutation in the RAX2 gene.
Features include sometimes findings: Photophobia. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Macular degeneration, Macular atrophy |
Muscles | 1 | Macular atrophy |
RAX2 function has not been fully characterized.
Cone-rod dystrophy 11 is associated with mutations in the RAX2 gene on chromosome 19.
Genetic testing for RAX2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cone-rod dystrophy 11 has been reported in the published literature.
No clinical trials have been registered for cone-rod dystrophy 11.
55 publications have been identified in PubMed for cone-rod dystrophy 11. Research spans Basic Science / Preclinical (33%), Epidemiology / Natural History (33%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 18 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 17, 2026, 11:31 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cone-rod dystrophy 11
18 |
33% |
Patient case studies | 8 | 15% |
Testing and diagnosis research | 4 | 7% |
Research summaries | 3 | 5% |
New treatment approaches | 2 | 4% |
Other research | 1 | 2% |
Clinical study results | 1 | 2% |
Rodriguez-Martinez AC (2026). [PMID: 41626423](https://pubmed.ncbi.nlm.nih.gov/41626423/). *Ophthalmol Sci*. [Basic Science / Preclinical]
Mizobuchi K (2026). [PMID: 42102949](https://pubmed.ncbi.nlm.nih.gov/42102949/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Raji S (2026). [PMID: 41481301](https://pubmed.ncbi.nlm.nih.gov/41481301/). *JAMA Ophthalmol*. [Epidemiology / Natural History]
Huang J (2026). [PMID: 42274835](https://pubmed.ncbi.nlm.nih.gov/42274835/). *Doc Ophthalmol*. [Case Report / Case Series]
de Guimarães TAC (2026). [PMID: 42071308](https://pubmed.ncbi.nlm.nih.gov/42071308/). *Ophthalmic Genet*. [Diagnostic / Biomarker]
Khan AO (2026). [PMID: 41166683](https://pubmed.ncbi.nlm.nih.gov/41166683/). *Retina*. [Epidemiology / Natural History]
Zhou Y (2026). [PMID: 41933583](https://pubmed.ncbi.nlm.nih.gov/41933583/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Demirkol A (2026). [PMID: 41751276](https://pubmed.ncbi.nlm.nih.gov/41751276/). *Biomedicines*. [Diagnostic / Biomarker]
Li S (2026). [PMID: 41775632](https://pubmed.ncbi.nlm.nih.gov/41775632/). *J Neurosci*. [Epidemiology / Natural History]
Zhang L (2025). [PMID: 41117592](https://pubmed.ncbi.nlm.nih.gov/41117592/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]